デフォルト表紙
市場調査レポート
商品コード
1554024

小児耳鼻咽喉科の市場規模、シェア、動向分析レポート:製品別、地域別、セグメント予測、2024年~2030年

Pediatric ENT Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 150 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
小児耳鼻咽喉科の市場規模、シェア、動向分析レポート:製品別、地域別、セグメント予測、2024年~2030年
出版日: 2024年08月06日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

小児耳鼻咽喉科市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の小児耳鼻咽喉科の市場規模は2030年までに101億7,000万米ドルに達すると予測され、2024年から2030年までのCAGRは5.02%で成長すると予測されています。

小児の耳鼻咽喉科疾患の早期診断と治療が重視されるようになっています。このような認識により、親やヘルスケアプロバイダーは先進的な診断装置や治療オプションを求めるようになり、市場成長をさらに促進しています。

小児用人工内耳における最近の進歩には、2022年11月に9~24カ月の小児への使用がFDAから承認されたCochlear Nucleus 8 Sound Processorのイントロダクションが含まれます。このプロセッサは、最もパワフルで最小のBTE(Behind-The-Ear)人工内耳サウンドプロセッサであり、Bluetooth LE Audio技術を搭載しているため、家電製品に直接オーディオ接続が可能です。この技術革新は、環境の変化に自動的に適応し、会話中のバックグラウンドノイズを低減することで、子供たちのリスニング体験を向上させることを目的としています。

同市場は、最近のFDA承認や小児用医療機器の普及に向けた取り組みに大きく影響され、成長を遂げています。2023年12月、Acclarent社は、繰り返し耳チューブを必要とする小児に対する新しい治療オプションのFDA認可を取得した最初で唯一の企業となった。

小児耳鼻咽喉科市場レポートハイライト

  • 診断用耳鼻咽喉科機器分野は、2023年に57.15%の最大売上シェアで市場をリードしました。聴覚インプラント分野は予測期間中に最も速いCAGRで成長する見込みです。これは、非侵襲的な方法として人工内耳への嗜好が高まっていることに起因しています。
  • 北米は、デジタルヘルスインフラの改善、ヘルスケア支出の増加、主要耳鼻咽喉科機器メーカーの存在により、2023年の収益シェア34.14%で市場を独占しました。
  • FDAは、小児特有のニーズを認識し、小児用医療機器の開発と承認を積極的に推進しています。これには、小児用と表示された機器の数を増やし、諮問委員会に小児の専門家を参加させることで、低年齢層の安全性と有効性を確保することが含まれます。
  • 2023年8月、フォナックは、未治療の片耳難聴者、10代、小児、重度の難聴を抱える成人の方々により良い製品を提供するため、ルミティプラットフォームの新たな進化を発表しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • ポーターのファイブフォース分析
    • PESTLE分析

第4章 小児耳鼻咽喉科市場:製品別推定・動向分析

  • 製品セグメントダッシュボード
  • 製品市場シェア、2023年および2030年
  • 市場規模と予測および動向分析、製品別、2018~2030年
  • 診断用耳鼻咽喉科機器
  • 外科手術用耳鼻咽喉科機器
  • 補聴器
  • 聴覚インプラント
  • 鼻スプリント

第5章 小児耳鼻咽喉科市場:地域別推定・動向分析

  • 地域市場ダッシュボード
  • 地域市場:重要なポイント
  • 北米
    • 北米小児耳鼻咽喉科市場推計・予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の小児耳鼻咽喉科市場推計・予測、2018年-2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋の小児耳鼻咽喉科機器市場推計・予測、2018年-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの小児耳鼻咽喉科機器市場推計・予測、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ小児耳鼻咽喉科機器市場推計・予測、2018-2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参入企業概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/リスト
    • Medtronic
    • Karl Storz
    • Stryker Corporation
    • Smith &Nephew plc
    • Olympus Corporation
    • Cochlear Ltd.
    • Demant A/S
    • GN Store Nord A/S
    • Ambu A/S
    • Pentax Medical
    • FUJIFILM Holdings
    • Acclarent
    • Preceptis Medical
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global pediatric ENT market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America pediatric ENT market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 9 Mexico pediatric ENT market, by teatment, 2018 - 2030 (USD Million)
  • Table 10 Europe pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 11 UK pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 12 Germany pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 13 France pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 14 Italy pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 15 Spain pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 16 Norway pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 17 Sweden pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 18 Denmark pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific pediatric ENT market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 21 Japan pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 22 China pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 23 India pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 24 Australia pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 25 South Korea pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 26 Thailand pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 27 Latin America pediatric ENT market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 29 Brazil pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 30 Argentina pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa pediatric ENT market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 33 South Africa pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 35 UAE pediatric ENT market, by product, 2018 - 2030 (USD Million)
  • Table 36 Kuwait pediatric ENT market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Pediatric ENT market: Product outlook and key takeaways
  • Fig. 17 Pediatric ENT market: Product movement analysis
  • Fig. 18 Diagnostic ENT devices market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 Surgical ENT devices market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 Hearing aids market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 Hearing implants market revenue, 2018 - 2030 (USD Million)
  • Fig. 22 Nasal Splints market revenue, 2018 - 2030 (USD Million)
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 Regional outlook, 2023 & 2030
  • Fig. 25 Pediatric ENT market: Region movement analysis
  • Fig. 26 North America pediatric ENTdevices market, 2018 - 2030, (USD Million)
  • Fig. 27 US key country dynamics
  • Fig. 28 US pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 29 Canada key country dynamics
  • Fig. 30 Canada pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico key country dynamics
  • Fig. 32 Mexico pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 34 UK key country dynamic
  • Fig. 35 UK pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany key country dynamic
  • Fig. 37 Germany pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 38 France key country dynamic
  • Fig. 39 France pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy key country dynamic
  • Fig. 41 Italy pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain key country dynamic
  • Fig. 43 Spain pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark key country dynamic
  • Fig. 45 Denmark pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden key country dynamic
  • Fig. 47 Sweden pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway key country dynamic
  • Fig. 49 Norway pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 51 China key country dynamic
  • Fig. 52 China pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan key country dynamic
  • Fig. 54 Japan pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 55 India key country dynamic
  • Fig. 56 India pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea key country dynamic
  • Fig. 58 South Korea pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia key country dynamic
  • Fig. 60 Australia pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand key country dynamic
  • Fig. 62 Thailand pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil key country dynamic
  • Fig. 65 Brazil pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina key country dynamic
  • Fig. 67 Argentina pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 68 MEA pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa key country dynamic
  • Fig. 70 South Africa pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia key country dynamic
  • Fig. 72 Saudi Arabia pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE key country dynamic
  • Fig. 74 UAE pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait key country dynamic
  • Fig. 76 Kuwait pediatric ENT market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig. 78 Strategy mapping
  • Fig. 79 Company market position analysis
目次
Product Code: GVR-4-68040-395-3

Pediatric ENT Market Growth & Trends:

The global pediatric ENT market size is anticipated to reach at USD 10.17 billion by 2030 and is projected to grow at a CAGR of 5.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. There is an increasing emphasis on early diagnosis and treatment of ENT disorders in children. This awareness drives parents and healthcare providers to seek out advanced diagnostic devices and treatment options, further propelling market growth.

Recent advancements in cochlear implants for pediatric patients include the introduction of the Cochlear Nucleus 8 Sound Processor, which received FDA approval for use in children aged 9 to 24 months in November 2022. This processor is noteworthy for being the most powerful and smallest Behind-The-Ear (BTE) cochlear implant sound processor available, and it has Bluetooth LE Audio technology, allowing direct audio connectivity to consumer electronics. This innovation aims to enhance the listening experience for children by automatically adjusting to environmental changes and reducing background noise during conversations.

Themarket is experiencing growth, significantly influenced by recent FDA approvals and initiatives aimed at enhancing the availability of medical devices specifically designed for children. In December 2023, Acclarent became the first and only company to receive FDA clearance for a new treatment option for children requiring repeat ear tubes.

Pediatric ENT Market Report Highlights:

  • The diagnostic ENT devices segment led the market with the largest revenue share of 57.15% in 2023. The hearing implant segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing preference for cochlear implants as non-invasive methods.
  • North America dominated the market with the revenue share of 34.14% in 2023, owing to improving digital health infrastructure, rising healthcare expenditure, and presence of major ENT device manufacturers.
  • The FDA is actively promoting the development and approval of pediatric medical devices, recognizing the unique needs of children. This includes increasing the number of devices labeled for pediatric use and involving pediatric experts in advisory panels to ensure safety and efficacy for younger populations.
  • In August 2023, Phonak launched new advancements for its Lumity platform to better cater to individuals with untreated hearing loss in one ear and teens, children, and adults those with severe-to-severe hearing loss.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High prevalence of hearing loss
      • 3.2.1.2. Increasing penetration of minimally invasive pediatric ENT procedures
      • 3.2.1.3. Technological advancements in pediatric ENT devices
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of hearing devices
      • 3.2.2.2. The absence of adequate reimbursement for certain ENT procedures
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Pediatric ENT Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Product Market Share, 2023 & 2030
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Diagnostic ENT Devices
    • 4.4.1. Diagnostic ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Surgical ENT Devices
    • 4.5.1. Surgical ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Hearing Aids
    • 4.6.1. Hearing aids market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hearing Implants
    • 4.7.1. Hearing implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Nasal Splints
    • 4.8.1. Nasal splints market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pediatric ENT Market Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamic
      • 5.3.2.2. Regulatory framework
      • 5.3.2.3. Competitive insights
      • 5.3.2.4. U.S. pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamic
      • 5.3.3.2. Regulatory framework
      • 5.3.3.3. Competitive insights
      • 5.3.3.4. Canada pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamic
      • 5.3.4.2. Regulatory framework
      • 5.3.4.3. Competitive insights
      • 5.3.4.4. Mexico pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamic
      • 5.4.2.2. Regulatory framework
      • 5.4.2.3. Competitive insights
      • 5.4.2.4. Germany pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. UK
      • 5.4.3.1. Key country dynamic
      • 5.4.3.2. Regulatory framework
      • 5.4.3.3. Competitive insights
      • 5.4.3.4. UK pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamic
      • 5.4.4.2. Regulatory framework
      • 5.4.4.3. Competitive insights
      • 5.4.4.4. France pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamic
      • 5.4.5.2. Regulatory framework
      • 5.4.5.3. Competitive insights
      • 5.4.5.4. Italy pediatric ENT market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamic
      • 5.4.6.2. Regulatory framework
      • 5.4.6.3. Competitive insights
      • 5.4.6.4. Spain pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Denmark
      • 5.4.7.1. Key country dynamic
      • 5.4.7.2. Regulatory framework
      • 5.4.7.3. Competitive insights
      • 5.4.7.4. Denmark pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key country dynamic
      • 5.4.8.2. Regulatory framework
      • 5.4.8.3. Competitive insights
      • 5.4.8.4. Sweden pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key country dynamic
      • 5.4.9.2. Regulatory framework
      • 5.4.9.3. Competitive insights
      • 5.4.9.4. Norway pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key country dynamic
      • 5.5.2.2. Regulatory framework
      • 5.5.2.3. Competitive insights
      • 5.5.2.4. Japan pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key country dynamic
      • 5.5.3.2. Regulatory framework
      • 5.5.3.3. Competitive insights
      • 5.5.3.4. China pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamic
      • 5.5.4.2. Regulatory framework
      • 5.5.4.3. Competitive insights
      • 5.5.4.4. India pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamic
      • 5.5.5.2. Regulatory framework
      • 5.5.5.3. Competitive insights
      • 5.5.5.4. South Korea pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Australia
      • 5.5.6.1. Key country dynamic
      • 5.5.6.2. Regulatory framework
      • 5.5.6.3. Competitive insights
      • 5.5.6.4. Australia pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key country dynamic
      • 5.5.7.2. Regulatory framework
      • 5.5.7.3. Competitive insights
      • 5.5.7.4. Thailand pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamic
      • 5.6.2.2. Regulatory framework
      • 5.6.2.3. Competitive insights
      • 5.6.2.4. Brazil pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamic
      • 5.6.3.2. Regulatory framework
      • 5.6.3.3. Competitive insights
      • 5.6.3.4. Argentina pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key country dynamic
      • 5.7.2.2. Regulatory framework
      • 5.7.2.3. Competitive insights
      • 5.7.2.4. South Africa pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key country dynamic
      • 5.7.3.2. Regulatory framework
      • 5.7.3.3. Competitive insights
      • 5.7.3.4. Saudi Arabia pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamic
      • 5.7.4.2. Regulatory framework
      • 5.7.4.3. Competitive insights
      • 5.7.4.4. UAE pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamic
      • 5.7.5.2. Regulatory framework
      • 5.7.5.3. Competitive insights
      • 5.7.5.4. Kuwait pediatric ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Medtronic
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Service benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Karl Storz
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Stryker Corporation
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. Smith & Nephew plc
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Olympus Corporation
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Cochlear Ltd.
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Demant A/S
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. GN Store Nord A/S
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Ambu A/S
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Pentax Medical
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. FUJIFILM Holdings
      • 6.5.11.1. Overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Acclarent
      • 6.5.12.1. Overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Preceptis Medical
      • 6.5.13.1. Overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives